BTIG Research Sees Shire's Dominance In ADHD Treatment Space Yielding A Long Runway Of Patent Protection, Believes SHP465 Could Offer Longer Duration Of Coverage Vs. Adderall XR, Maintains Buy & $230 PT
Paul Quintaro